Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

FIT Biotech Oy: Correction to English company release: Conversion of FIT Biotech Oy's Convertible Notes into shares

FIT Biotech Oy
Posted on: 14 Oct 16

FIT Biotech Oy

Company release October 14, 2016 at 1 pm EET

Correction to English company release: Conversion of FIT Biotech Oy's Convertible Notes into shares

FIT Biotech Oy's company release published on October 14, 2016 at 9.30 am EET contained an error related to the amount of new K shares issued by the Company to Bracknor due to the conversion of Convertible Notes. The correct number of new K shares is 124,890 as stated in the Finnish company release.


Board of Directors

For further information:
Chairman of the Board of Directors Juha Vapaavuori
Tel: +358 50 372 0824

Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000

About FIT Biotech
FIT Biotech Oy is a biotechnology company established in 1995. The company develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.

FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases such as HIV and tuberculosis, as well as animal vaccines.

FIT Biotech shares are listed on the First North Finland marketplace maintained by Nasdaq Helsinki Oy.

Principal media

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: FIT Biotech Oy via GlobeNewswire

Last updated on: 15/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.